What is the treatment for urticaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Urticaria

Second-generation H1-antihistamines are the first-line treatment for urticaria, with doses that can be increased up to four times the standard dose for refractory cases. 1

Initial Management

First-Line Treatment

  • Start with a second-generation H1-antihistamine at standard dosing:
    • Fexofenadine 180mg daily
    • Cetirizine 10mg daily
    • Loratadine 10mg daily 1

Step-Up Approach

If inadequate response after 1-2 weeks:

  1. Step 1: Standard dose second-generation H1-antihistamine
  2. Step 2: Increase dose up to 4× standard dose if inadequate response
  3. Step 3: Add leukotriene receptor antagonist (e.g., montelukast) or consider advanced therapies 1

Treatment Based on Urticaria Type

Chronic Spontaneous Urticaria

  • For patients ≥12 years with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment, omalizumab is FDA-approved 2
  • Dosing of omalizumab for CSU is not dependent on serum IgE levels or body weight 2
  • Validated tools like Urticaria Control Test (UCT) and Urticaria Activity Score (UAS7) should be used to monitor disease control 1

Acute Urticaria

  • Most cases are self-limited and resolve within days to weeks with appropriate treatment 1
  • Limited evidence suggests that adding systemic corticosteroids to antihistamines does not significantly improve symptoms 3

Physical Urticarias

  • For symptomatic dermographism, combination therapy with H1 antihistamines and H2 antagonists (e.g., cimetidine, ranitidine) has shown better efficacy than H1 antihistamines alone 1, 4

Advanced Treatment Options for Refractory Cases

Third-Line Options

For patients with inadequate response to high-dose antihistamines:

  • Omalizumab: Particularly effective for chronic spontaneous urticaria 1, 2
  • Cyclosporine: For resistant cases 1
  • Other alternatives: Tacrolimus, mycophenolate mofetil, dapsone, sulfasalazine, and tranexamic acid 1

Topical Treatments

  • Topical doxepin may provide relief but should be limited to 8 days and 10% of body surface area (maximum 12g daily) due to risk of allergic contact dermatitis 1

Special Considerations

Anaphylaxis Management

  • If urticaria is accompanied by signs of anaphylaxis (respiratory distress, vomiting, lethargy):
    • Administer epinephrine 0.3 mg IM in the mid-antrolateral thigh as first-line treatment
    • Follow with combined H1+H2 blockade (diphenhydramine 1-2 mg/kg or 25-50 mg IV plus ranitidine 50 mg IV)
    • Seek immediate emergency medical attention 1

First-Generation Antihistamines

  • Use cautiously due to sedative effects
  • May be useful for nighttime symptoms when pruritus interferes with sleep 1
  • Examples include diphenhydramine and hydroxyzine

Monitoring and Follow-Up

  • Reassess within 1-2 weeks of initiating or changing therapy 1
  • Follow the principle of "as much as needed and as little as possible" for medication use 1
  • Extensive laboratory workup is unnecessary for most cases of urticaria unless specific underlying conditions are suspected 1

Common Pitfalls to Avoid

  1. Inadequate dosing: Many patients require higher than standard antihistamine doses. Studies show approximately 75% of patients with difficult-to-treat chronic urticaria respond to higher than conventional antihistamine doses 5

  2. Premature discontinuation: More than half of patients with chronic urticaria will have resolution or improvement of symptoms within a year, so continued treatment may be necessary 6

  3. Missing anaphylaxis: Failure to identify anaphylaxis can be critical. Always assess for systemic symptoms 1

  4. Overuse of corticosteroids: Limited evidence supports their routine use in acute urticaria 3

References

Guideline

Urticaria Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of acute urticaria: A systematic review.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Research

Treatment of urticaria. An evidence-based evaluation of antihistamines.

American journal of clinical dermatology, 2001

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.